 WEST CONSHOHOCKEN, Pa., May 18, 2021 GLOBE NEWSWIRE -- Madrigal Pharmaceuticals, Inc. NASDAQ:MDGL, a clinical-stage biopharmaceutical company pursuing novel therapeutics for cardio-metabolic and fatty liver diseases with high unmet medical need, announced today that Alex Howarth has joined Madrigal as Chief Financial Officer. 